Catheter Historical Income Statement
| VTAK Stock | 0.35 0.02 5.41% |
Historical analysis of Catheter Precision income statement accounts such as Depreciation And Amortization of 1.3 M, Interest Expense of 3.7 M, Total Revenue of 419.9 K or Gross Profit of 259.3 K can show how well Catheter Precision performed in making a profits. Evaluating Catheter Precision income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Catheter Precision's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Catheter Precision latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Catheter Precision is a good buy for the upcoming year.
Catheter |
About Catheter Income Statement Analysis
Catheter Precision Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Catheter Precision shareholders. The income statement also shows Catheter investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Catheter Precision Income Statement Chart
Add Fundamental
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Cost Of Revenue
Cost of Revenue is found on Catheter Precision income statement and represents the costs associated with goods and services Catheter Precision provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Catheter Precision's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Catheter Precision current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.At this time, Catheter Precision's Interest Expense is quite stable compared to the past year. Total Operating Expenses is expected to rise to about 82.5 M this year, although the value of Gross Profit will most likely fall to about 259.3 K.
| 2021 | 2023 | 2024 (projected) | Interest Expense | 3.1M | 3.5M | 3.7M | Depreciation And Amortization | 1.6M | 2.1M | 1.3M |
Catheter Precision income statement Correlations
Click cells to compare fundamentals
Catheter Precision Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Catheter Precision income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 1.8M | 2.4M | 1.6M | 421K | 2.1M | 1.3M | |
| Interest Expense | 14K | 250K | 108K | 3.1M | 3.5M | 3.7M | |
| Total Revenue | 7.2M | 4.4M | 22K | 14K | 442K | 419.9K | |
| Gross Profit | (1.7M) | (1.1M) | (1.5M) | (147K) | 412K | 259.3K | |
| Other Operating Expenses | 64.9M | 40.5M | 29.3M | 22.8M | 78.6M | 42.2M | |
| Operating Income | (57.7M) | (36.1M) | (29.3M) | (27.0M) | (78.1M) | (74.2M) | |
| Ebit | (57.7M) | (36.1M) | (29.3M) | (22.8M) | (17.2M) | (18.0M) | |
| Research Development | 4.5M | 9.0M | 12.3M | 6.4M | 475K | 451.3K | |
| Ebitda | (56.0M) | (33.7M) | (27.7M) | (22.4M) | (15.1M) | (15.9M) | |
| Cost Of Revenue | 8.9M | 5.5M | 1.6M | 161K | 30K | 28.5K | |
| Total Operating Expenses | 56.1M | 35.0M | 27.7M | 22.6M | 78.5M | 82.5M | |
| Income Before Tax | (56.9M) | (36.0M) | (27.3M) | (26.9M) | (70.6M) | (67.0M) | |
| Total Other Income Expense Net | 788K | 21K | 2.0M | (4.1M) | 7.5M | 7.9M | |
| Net Income | (57.0M) | (36.0M) | (25.1M) | (26.9M) | (70.6M) | (67.0M) | |
| Income Tax Expense | 15K | 7K | 4K | 3K | 60.6M | 63.6M | |
| Selling General Administrative | 51.5M | 26.0M | 15.5M | 2.2M | 17.1M | 19.0M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catheter Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 30.61 | Revenue Per Share 0.604 | Quarterly Revenue Growth (0.03) | Return On Assets (0.22) | Return On Equity (0.50) |
The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catheter Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.